Human adipose-derived stem cell adipogenesis induces paracrine regulation of the invasive ability of MCF-7 human breast cancer cells in vitro

Zhao,Yang; Gao,Jianhua; Lu,Feng

doi:10.3892/etm.2013.1237

Human adipose-derived stem cell adipogenesis induces paracrine regulation of the invasive ability of MCF-7 human breast cancer cells in vitro

Authors:
- Yang Zhao
- Jianhua Gao
- Feng Lu
View Affiliations

Affiliations: Department of Plastic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China
Published online on: July 30, 2013 https://doi.org/10.3892/etm.2013.1237
Pages: 937-942

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to determine the effects of paracrine regulation on the invasive ability of MCF‑7 human breast cancer cells through human adipose‑derived stem cell (hADSC) adipogenesis. hADSC differentiation of the third and fourth passages of cells was induced in different induction media: osteogenic, adipogenic and chondrogenic. Transwell migration assays in the differently conditioned media, flow cytometry, enzyme‑linked immunosorbent assay and western blot analysis for selected cytokines were performed. The flow cytometric analysis demonstrated positive expression of CD29, CD44 and CD105, while expression of CD34 and CD45 was not identified. The transwell migration assay showed that the invasive ability of MCF‑7 cells was significantly enhanced during hADSC adipogenesis. hADSCs exerted a significantly positive effect on the invasive activity of MCF‑7 cells during adipogenesis. The results indicate that the high expression levels of activating protein 2 (aP2) in MCF‑7 and adipocytes induced for 12 days may be associated with cell growth, invasion and metastasis. Peroxisome proliferator-activated receptor γ may be involved in fatty syntheses during adipogenic initiation and following adipogenic differentiation, possibly acting as a protection factor resulting in cell maturation and differentiation. This study also demonstrated that the expression of vascular endothelial growth factor was repressed by hADSCs, while that of matrix metalloproteinase‑2 and urokinase‑type plasminogen activator was increased to a significant level.

View Figures

View References

1.	Bucky LP and Percec I: The science of autologous fat grafting: views on current and future approaches to neoadipogenesis. Aesthet Surg J. 28:313–321. 2008. View Article : Google Scholar : PubMed/NCBI
2.	Hsu VM, Stransky CA, Bucky LP and Percec I: Fat grafting’s past, present, and future: why adipose tissue is emerging as a critical link to the advancement of regenerative medicine. Aesthet Surg J. 32:892–899. 2012.
3.	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
4.	Trojahn Kølle SF, Oliveri RS, Glovinski PV, Elberg JJ, Fischer-Nielsen A and Drzewiecki KT: Importance of mesenchymal stem cells in autologous fat grafting: a systematic review of existing studies. J Plast Surg Hand Surg. 46:59–68. 2012.PubMed/NCBI
5.	Philips BJ, Marra KG and Rubin JP: Adipose stem cell-based soft tissue regeneration. Expert Opin Biol Ther. 12:155–163. 2012. View Article : Google Scholar : PubMed/NCBI
6.	Watanabe M, Inukai K, Katagiri H, Awata T, Oka Y and Katayama S: Regulation of PPAR gamma transcriptional activity in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 300:429–436. 2003. View Article : Google Scholar : PubMed/NCBI
7.	Moldes M, Zuo Y, Morrison RF, et al: Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. Biochem J. 376:607–613. 2003. View Article : Google Scholar : PubMed/NCBI
8.	Wu Z, Rosen ED, Brun R, et al: Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell. 3:151–158. 1999. View Article : Google Scholar : PubMed/NCBI
9.	Prusty D, Park BH, Davis KE and Farmer SR: Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem. 277:46226–46232. 2002. View Article : Google Scholar
10.	Crowe DL and Chandraratna RA: A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands. Breast Cancer Res. 6:R546–R555. 2004. View Article : Google Scholar
11.	Yadav S, Anbalagan M, Shi Y, Wang F and Wang H: Arsenic inhibits the adipogenic differentiation of mesenchymal stem cells by down-regulating peroxisome proliferator-activated receptor gamma and CCAAT enhancer-binding proteins. Toxicol In Vitro. 27:211–219. 2013. View Article : Google Scholar
12.	Lo Furno D, Graziano AC, Caggia S, et al: Decrease of apoptosis markers during adipogenic differentiation of mesenchymal stem cells from human adipose tissue. Apoptosis. 18:578–588. 2013.PubMed/NCBI
13.	Dong YW, Wang XP and Wu K: Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition. World J Gastroenterol. 15:441–448. 2009. View Article : Google Scholar
14.	Fenner MH and Elstner E: Peroxisome proliferator-activated receptor-gamma ligands for the treatment of breast cancer. Expert Opin Investig Drugs. 14:557–568. 2005. View Article : Google Scholar : PubMed/NCBI
15.	Pellikainen JM and Kosma VM: Activator protein-2 in carcino-genesis with a special reference to breast cancer - a mini review. Int J Cancer. 120:2061–2067. 2007. View Article : Google Scholar : PubMed/NCBI
16.	Zuk PA, Zhu M, Mizuno H, et al: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7:211–228. 2001. View Article : Google Scholar : PubMed/NCBI
17.	Wieczorek E, Reszka E, Gromadzinska J and Wasowicz W: Genetic polymorphism of matrix metalloproteinases in breast cancer. Neoplasma. 59:237–247. 2012. View Article : Google Scholar : PubMed/NCBI
18.	Velinov N, Poptodorov G, Gabrovski N and Gabrovski S: The role of matrix metalloproteinases in the tumor growth and metastasis. Khirurgiia (Sofiia). 1:44–49. 2010.(In Bulgarian).
19.	Kunigal S, Lakka SS, Gondi CS, Estes N and Rao JS: RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth. Int J Cancer. 121:2307–2316. 2007. View Article : Google Scholar
20.	Lakka SS, Gondi CS, Dinh DH, et al: Specific interference of urokinase-type plasminogen activator receptor and matrix metal-loproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas. J Biol Chem. 280:21882–21892. 2005. View Article : Google Scholar
21.	Tang L and Han X: The urokinase plasminogen activator system in breast cancer invasion and metastasis. Biomed Pharmacother. 67:179–182. 2013. View Article : Google Scholar : PubMed/NCBI
22.	Holst-Hansen C, Johannessen B, Hoyer-Hansen G, Romer J, Ellis V and Brunner N: Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness. Clin Exp Metastasis. 14:297–307. 1996.PubMed/NCBI
23.	Wang XF, Zhou QM, Du J, Zhang H, Lu YY and Su SB: Baicalin suppresses migration, invasion and metastasis of breast cancer via p38MAPK signaling pathway. Anticancer Agents Med Chem. 13:923–931. 2013. View Article : Google Scholar : PubMed/NCBI
24.	Jezierska A and Motyl T: Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med Sci Monit. 15:RA32–RA40. 2009.PubMed/NCBI
25.	Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID and Sogayar C: Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer. 9:202009. View Article : Google Scholar
26.	Perera RJ, Marcusson EG, Koo S, et al: Identification of novel PPARgamma target genes in primary human adipocytes. Gene. 369:90–99. 2006. View Article : Google Scholar : PubMed/NCBI